Abstract:Hepatitis B virus-related acute-on-chronic liver failure (HBV–ACLF) is frequently accompanied by short-term morbidity and mortality. However, there have been no studies on the associations between baseline clinicopathologic characteristics at hospital admission and clinical prognosis after receiving artificial liver therapy. Therefore, the current study aimed to develop a prognostic nomogram for predicting the outcomes of patients with HBV–ACLF following artificial liver support. A retrospective study of 110 consecutive patients who were diagnosed with HBV–ACLF between January 2018 and August 2022 was conducted. First, univariate and multivariate logistic regression analyses were performed to determine the independent prognostic factors significantly associated with patient outcomes. Moreover, a predictive nomogram model underlying the prognostic factors was established and further evaluated. The area under the curve (AUC) was used to gauge the predictive accuracy. The calibration curve and decision curve analysis (DCA) were employed to assess the discriminability and clinical effectiveness, respectively. In patients with HBV–ACLF, multivariate logistic analysis revealed that age ≥ 40 years (OR 6.76, p = 0.025), middle-stage liver failure (OR 49.96, p < 0.001), end-stage liver failure (OR 19.27, p = 0.002), hepatic encephalopathy (OR 7.06, p = 0.032), upper gastrointestinal hemorrhage (OR 47.24, p = 0.047), and artificial liver therapy consisting of plasma exchange (PE) + plasma exchange double plasma molecular adsorption system (DPMAS) (OR 0.26, p = 0.04) were identified as prognostic factors. Then, we established and evaluated a predictive nomogram with an AUC of 0.885, which showed better predictive accuracy than the model for end-stage liver disease (MELD) score (AUC of 0.634) and the Child–Pugh score (AUC of 0.611). Moreover, the calibration curve showed good agreement between the ideal and bias-corrected curves. Decision curve analysis confirmed the better clinical utility of this approach. We developed and evaluated a unique nomogram that was more accurate than conventional prognostic models for predicting the clinical prognosis of HBV–ACLF patients receiving artificial liver therapy. As a result, the nomogram may be a helpful tool in clinical decision-making to predict the outcomes of patients with HBV–ACLF.

A Nomogram to Predict Survival in Patients with Acute-on-chronic Hepatitis B Liver Failure after Liver Transplantation

A Novel Nomogram to Predict 90-Day Mortality in Patients with Hepatitis B Virus-Related Acute-on-chronic Liver Failure: a Single-Center Retrospective Study

Prognostic Nomogram for Patients with Hepatitis E Virus-related Acute Liver Failure: A Multicenter Study in China

Development and Validation of a Novel Prognostic Nomogram for Hepatitis B Virus-Related Acute-on-chronic Liver Failure Patients Receiving Artificial Liver Therapy

Derivation and Validation of a Nomogram for Predicting 90-Day Survival in Patients With HBV-Related Acute-on-Chronic Liver Failure

Nomogram prediction of individual prognosis of patients with acute-on-chronic hepatitis B liver failure.

Nomogram based on blood lipoprotein for estimation of mortality in patients with hepatitis B virus-related acute-on-chronic liver failure

A Nomogram for Predicting Prognostic Value of Inflammatory Biomarkers in Patients with Acute-on-chronic Liver Failure.

Nomograms to Predict Prognosis of Hepatocelluar Carcinoma Without Major Vascular Invasion after Primary Liver Transplantation

Development of a nomogram for predicting liver transplantation prognosis in hepatocellular carcinoma

A Preoperative Nomogram Predicts Prognosis of Patients with Hepatocellular Carcinoma after Liver Transplantation: a Multicenter Retrospective Study

Development and Validation of a Nomogram to Predict Allograft Survival after Pediatric Liver Transplantation.

Nomograms for Survival Prediction in Patients Undergoing Liver Resection for Hepatitis B Virus Related Early Stage Hepatocellular Carcinoma.

Development of a Predictive Nomogram for Early Recurrence of Hepatocellular Carcinoma in Patients Undergoing Liver Transplantation.

Nomogram Based on Albumin-Bilirubin Grade to Predict Outcome of the Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma after Microwave Ablation.

Development and validation of the nomogram based on INR and eGFR for estimation of mortality in patients with acute-on-chronic hepatitis B liver failure

Establishing a Metabolomic Model for the Prognosis of Hepatitis B Virus-Induced Acute-on-chronic Liver Failure Treated with Different Liver Support Systems

A Novel Nomogram to Predict the Recurrence of Hepatocellular Carcinoma after Liver Transplantation Using Extended Selection Criteria

Predictive Nomograms for Clinical Outcomes in Hepatitis B-Related Cirrhosis Patients Receiving Antiviral Therapy

Development and External Validation of a Prognostic Nomogram for Acute Decompensation of Chronic Hepatitis B Cirrhosis

A Novel Nomogram for Predicting Postoperative Liver Failure After Major Hepatectomy for Hepatocellular Carcinoma